Orazephin®

Home Orazephin

Orazephin®

INDICATION: Antibacterial

Orazephin® CR is an oral version of a widely used intravenous antibiotic Ceftriaxone.

Discover Orazephin®

Overview

Ceftriaxone is currently one of the most important and effective broad spectrum antibiotics used to treat over ten different infectious diseases including meningitis and post-surgical prophylaxis.

Phase

Orazephin® CR is currently in Phase I clinical trial.

US Market ($B USD)

The estimated market for Orazephin® in the United States is $0.75 Billion USD.

Global Market ($B USD)

The estimated market for Orazephin® globally is $1.3 Billion USD.

Inquire About Orazephin®